The STEP study provides a hint that vaccine induction of the right CD8 + T cell responses can facilitate immune control of HIV

Journal of Infectious Diseases

Volumn 203, Issue 6, 2011, Pages 753-755

  Altfeld, Marcus ^a   Goulder, Philip J ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTIRETROVIRUS AGENT; CD8 ANTIGEN; GAG PROTEIN; HLA ANTIGEN CLASS 1; HLA B27 ANTIGEN; HLA B57 ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEF PROTEIN; PLACEBO; POL PROTEIN; VIRUS ANTIBODY; VIRUS RNA;

ANTIBODY TITER; ANTIGEN EXPRESSION; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DISEASE FREE SURVIVAL; DRUG TREATMENT FAILURE; EDITORIAL; FOLLOW UP; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; INFECTION RISK; POPULATION GENETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); VIRUS LOAD;

AIDS VACCINES; CD8-POSITIVE T-LYMPHOCYTES; GENE FREQUENCY; GENE PRODUCTS, GAG; HIV INFECTIONS; HIV-1; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 79952346402     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jiq119     Document Type: Editorial

References (30)

1. McElrath MJ, De Rosa SC, Moodie Z, et al. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 2008; 372:1894-05.
2. Buchbinder SP, Mehrotra DV, Duerr A, et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008; 372:1881-93.
3. Corey L, McElrath MJ, Kublin JG. Post-step modifications for research on HIV vaccines. AIDS 2009; 23:3-8.
4. Robb ML. Failure of the Merck HIV vaccine: an uncertain step forward. Lancet 2008; 372:1857-8.
5. Uberla K. HIV vaccine development in the aftermath of the STEP study: re-focus on occult HIV infection? PLoS Pathog 2008; 4:e1000114.
6. Watkins DI, Burton DR, Kallas EG, Moore JP, Koff WC. Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans. Nat Med 2008; 14:617-21. (Pubitemid 351809543)
7. Moore JP, Klasse PJ, Dolan MJ, Ahuja SK. AIDS/HIV. A STEP into darkness or light? Science 2008; 320:753-5.
8. Sekaly RP. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J Exp Med 2008; 205:7-12.
9. Steinbrook R. One step forward, two steps back-will there ever be an AIDS vaccine? N Engl J Med 2007; 357:2653-5.
10. Pantaleo G. HIV-1 T-cell vaccines: evaluating the next step. Lancet Infect Dis 2008; 8:82-3.
11. Barouch DH, Korber B. HIV-1 vaccine development after STEP. Annu Rev Med 2010; 61:153-67.
12. Hutnick NA, Carnathan DG, Dubey SA, et al. Baseline Ad5 serostatus does not predict Ad5 HIV vaccine-induced expansion of adenovirus-specific CD4+ T cells. Nat Med 2009; 15:876-8.
13. O'Brien KL, Liu J, King SL, et al. Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans. Nat Med 2009; 15:873-5.
14. Benlahrech A, Harris J, Meiser A, et al. Adenovirus vector vaccination induces expansion of memory CD4 T cells with a mucosal homing phenotype that are readily susceptible to HIV-1. Proc Natl Acad Sci U S A 2009; 106:19940-5.
15. Kiepiela P, Ngumbela K, Thobakgale C, et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007; 13:46-53. (Pubitemid 46067385)
16. Goepfert PA, Lumm W, Farmer P, et al. Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med 2008; 205:1009-17. (Pubitemid 351679677)
17. Liu J, O'Brien KL, Lynch DM, et al. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 2009; 457:87-91.
18. Barouch DH, O'Brien KL, Simmons NL, et al. Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys. Nat Med 2010; 16:319-23.
19. Wilson NA, Keele BF, Reed JS, et al. Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge. J Virol 2009; 83:6508-21.
20. Goulder PJR, Watkins DI. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat Rev Immunol 2008; 8:619-30.
21. Altfeld M, Addo MM, Rosenberg ES, et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 2003; 17:2581-91. (Pubitemid 38402336)
22. Altfeld M, Kalife ET, Qi Y, et al. HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8(+) T cell response against HIV-1. PLoS Med 2006; 3:e403.
23. Leslie AJ, Pfafferott KJ, Chetty P, et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat Med 2004; 10:282-9. (Pubitemid 38667619)
24. Brockman MA, Schneidewind A, Lahaie M, et al. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A. J Virol 2007; 81:12608-18. (Pubitemid 350085874)
25. Streeck H, Jolin JS, Qi Y, et al. Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells. J Virol 2009; 83:7641-8.
26. Itoh Y, Mizuki N, Shimada T, et al. High throughout DNA typing of HLA-A, -B, -C and -DRB1 loci by a PCR-SSOP-Luminex method in the Japanese population. Immunogenetics 2005; 57:717-29. (Pubitemid 41598618)
27. Kawashima Y, Pfafferott K, Frater J, et al. Adaptation of HIV-1 to HLA I. Nature 2009; 458:641-5.
28. Honeyborne I, Prendergast A, Pereyra F, et al. Control of human immunodeficiency virus type 1 is associated with HLA-B*13 and targeting of multiple Gag-specific CD8+ T-cell epitopes. J Virol 2007; 81:3667-72. (Pubitemid 46456679)
29. Fellay J, Ge D, Shianna KV, et al. Common genetic variation and the control of HIV-1 in humans. PLoS Genet 2009; 5:e1000791.
30. Leslie A, Matthews PC, Listgarten J, et al. Additive contribution of HLA class I alleles in the immune control of HIV-1 infection. J Virol 2010. in press, July 21st epub.